Abbott Laboratories vs. Eton Pharmaceutcials, Inc. Common Stock
ABT
Abbott Laboratories
$110.37 -0.79%
VS ETONEton Pharmaceutcials, Inc. Common Stock
$61.73 +4.88%
Abbott Laboratories (ABT) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| ABT | ETON | |
|---|---|---|
| Market Cap | $192.51 billion | $1.68 billion |
| Revenue (TTM) | $46.59 billion | $105.59 million |
| Net Income (TTM) | $5.42 billion | $12.69 million |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | ETON | |
|---|---|---|
| P/E Ratio | 35.72 | — |
| Price / Book | 3.72 | 36.11 |
| Price / Sales | 4.13 | 15.93 |
ABT leads on 2 of 2 valuation factors.
Profitability
| ABT | ETON | |
|---|---|---|
| Net Margin | 11.65% | 12.02% |
| Return on Equity | 10.48% | 27.24% |
ETON leads on 2 of 2 profitability factors.
Dividend
| ABT | ETON | |
|---|---|---|
| Dividend Yield | 2.28% | — |
| Payout Ratio | 81.55 | — |
ABT and ETON split the dividend factors evenly.
Risk & Sentiment
| ABT | ETON | |
|---|---|---|
| Short Interest | 0.57% | 0.21% |
ETON leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, ETON overview, ETON financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.